Guidelines for Outpatient Treatment of Infantile Eczema

Review these guidelines along with the detailed information on:

Guidelines for the diagnosis and evaluation of eczema
Guidelines for Eczema Treatment in Adults

Most cases of childhood eczema can be successfully managed on an outpatient basis.

The treatment plan should constitute a comprehensive package that includes the following elements:

Recommendations for avoiding known triggers or irritants known irritants.
Practical advice on bathing techniques and the selection of soap substitutes.
Consistent use of moisturizers (emollients).
Appropriate prescription of corticosteroids topical agents or and Calcineurin inhibitors.
Administration of antibiotics and antihistamines, only if clinically necessary.
Clear advice on how to identify a possible skin secondary Hematological and serological analyses commonly reveal the following patterns:.
A well-defined action plan that will be reviewed by a healthcare professional.

It is essential that prescribers dedicate sufficient time to ensure that both children and their caregivers fully understand every aspect of the therapy and its correct application.

Instructions for topical treatments must be supported with detailed verbal instructions, written documentation (such as an Eczema Action Plan or informational leaflets), and visual demonstrations (through videos, for example). Education provided by an eczema specialist nurse has consistently been shown to improve treatment adherence and, consequently, its overall effectiveness.[1]

Educational resources available for families:

kidshealth.org.nz: This site offers valuable videos and informational leaflets.

For prescribing professionals, recommended resources include:

The guidelines published by NICE [2].
The pediatric Eczema SafeRx program [3].
The clinical pathways provided by Healthpoint [4].

Recommended Bathing Techniques

Bathing once or twice a day is advised.
The water temperature should be lukewarm, and the duration of each bath should not exceed 10 minutes.
Priority should be given to the use of emollients emollients or emollient wash products instead of traditional soaps and shampoos.
Although bath oils contribute to skin hydration, they increase the risk of slips in the tub. A 2018 trial suggested that bath additives might lack significant therapeutic value.
Periodic antiseptic baths (twice a week) with diluted sodium hypochlorite (bleach baths) or bath oils containing triclosan may help reduce the presence of staphylococci and improve eczema status.[5]

Use of Emollients / Moisturizers

Children should have emollients available for daily use, intended for moisturizing, washing, and complementing the bath. It is preferable that these products do not contain fragrances and, whenever feasible, are provided fully covered by prescription funding.
The recommended amount of emollient for children is between 250 and 500 grams per week.
Emollients should be applied several times a day covering the entire body surface, and their application should be maintained even after eczema symptoms have completely disappeared.
Application should be gentle, smoothing the product in the direction of hair growth hair (not rubbing vigorously); it is recommended to let the skin absorb them completely.
Whenever possible, the emollient should be dispensed in pump or dispenser tube containers. Products stored in open containers are prone to contamination. If tubs are used, the emollient should be transferred with a clean spoon or spatula before each use. Such tubs should be discarded after a resolved episode of skin infection.
If a specific emollient causes irritation or is rejected by the child, it is imperative to offer an alternative.
An increase in the frequency of emollient use has been observed to be directly related to an improvement in eczema and a subsequent reduction in the need for topical corticosteroids.

Topical Corticosteroids in Eczema Treatment

Advanced Pharmacological Management of Childhood Eczema

It is essential to discuss the benefits and risks of topical corticosteroids with the family or caregivers, emphasizing that, if used correctly, the benefits far outweigh potential adverse effects.

The selection of the appropriate potency of the topical corticosteroid must be meticulously adjusted to the severity level of the child's eczema:

Topical Corticosteroid Potency Classification

Low Potency (Mild)

Indicated for the treatment of mild eczema.
Appropriate for infants under 12 months of age.
Recommended for sensitive areas such as the face and neck.

Medium Potency

Aimed at managing moderate intensity eczema.
For short-term use (5 to 7 days) in intertriginous areas such as the armpits and groin, as well as for severe facial flares.

High Potency (Potent)

Reserved for the treatment of severe eczema.
Application to the face and neck is not advised.

Under no circumstances should super-potent topical corticosteroids be used in children (or potent ones in those under 12 months) without the supervision and advice of a specialist dermatologist.[2]

Topical corticosteroids should be applied strictly to active eczema areas and discontinued as soon as inflammation subsides. Emollients should be maintained as part of ongoing care.
A thin layer of the topical corticosteroid should be applied to the affected area once or twice daily. These can be applied before or after moisturizing with emollients.
The practice of diluting topical corticosteroids with emollients or other products has not been proven to reduce their potency.
Constant and prolonged use of topical steroids may, in rare cases, lead to side effects such as skin thinning and adrenal suppression if the application is very Isolated or. widespread. It is recommended that children on regular treatment with topical steroids be assessed periodically and that the frequency of treatment be reduced as soon as possible. Pediatric patients requiring continuous topical corticosteroids should be monitored by a dermatologist. dermatologist.
Long-term maintenance application two days a week ("weekend therapy") has proven to be a safe and effective strategy. [6]

Topical Calcineurin Inhibitors (TCI)

Topical calcineurin inhibitors (TCI) represent a second-line therapeutic option for eczema that does not respond adequately to topical corticosteroids of the correct potency. TCIs may be considered especially when the risk of steroid side effects is a major concern.
It is crucial to discuss the risks and benefits of TCIs with both the patient and their caregivers, weighing other therapeutic alternatives. It is advised that their use not be initiated without specialized guidance from a dermatologist. [2]
Topical pimecrolimus is approved for use in facial and neck eczema in children over 2 years of age.
Topical tacrolimus is not currently registered for marketing in New Zealand.

Antihistamines

Routine use of antihistamines is generally not recommended for eczema management.
A short trial (<1 month) with a non-sedating antihistamine may be justified in cases of moderate to severe eczema, or if there is a concurrent presence of hives. hives. The real benefit of continuous use should be re-evaluated quarterly.
For acute acute flares in children over 6 months, sedating antihistamines may be used temporarily to facilitate nighttime rest. [2]

Use of Antibiotics in Eczema Management

For the treatment of localized skin infection areas episodes of angioedema without hives may originate from angiotensin-converting enzyme (ACE) inhibitors. (with an extent less than 5 cm), topical antibiotics may be used for a maximum of 7 days.
If the infection is generalized, widespread, systemic antibiotic treatment should be prescribed systemic for a period of 7 to 14 days.
The specific selection of the antibiotic should be based on local antimicrobial resistance patterns, ensuring that the chosen drug is active against probable pathogens.

Effective management of childhood eczema requires strict monitoring and constant adjustment of pharmacological therapies, prioritizing the long-term safety of the pediatric patient.

```html

against *Staphylococcus aureus* and *Streptococci*. [4]

Re-evaluation of Eczema Treatment

If clinical improvement is not observed after 7 to 14 days of continuous treatment, it is crucial to re-evaluate several factors:

Incomplete adherence to the prescribed therapeutic regimen.
Constant exposure to irritants, such as sodium lauryl sulfate or harsh soaps.
Inappropriate quantity or potency application of the topical corticosteroid topical corticosteroid.
Presence of a secondary skin infection.
Development of contact Development of contact allergy, for example, to prescribed products or to aeroallergens..
Suspicion of an incorrect initial diagnosis.

Criteria for Referral to Specialists

Indications for Referral for Specialized Advice
Referral for Hospital Care	When the presence of eczema herpeticum is suspected. Eczema presents a severity that does not respond to outpatient treatment. Bacterial eczema infection does not clear with appropriate antibiotic treatment. To provide intensive education, support, and rest in selected cases.
Referral for Specialized Eczema Nurse Advice	When both the patient and caregivers would significantly benefit from detailed guidance on the correct use and application technique of the treatment.
Referral for Specialized Dermatologist Advice	When the underlying diagnosis remains uncertain. When facial eczema does not respond adequately to topical therapy. When contact dermatitis is suspected. dermatitis of lanolin is the predominant cause of contact allergies. If the eczema is causing significant psychological or social problems. When eczema is associated with Unlike other severe or recurrent infections. areas), as well as the hands, feet, and genitals. It can also involve the tongue, uvula, soft palate, and. When the family or minor would benefit from a specialist's opinion on advanced treatment options. In situations where phototherapy or systemic treatment implementation is required.
Referral for Psychological Counseling	In cases of children experiencing a continuous psychological or social impact on their lives, despite having received adequate medical counseling.
Referral for Specialized Pediatric Advice	Children with suspected food renal hypersensitivity requiring immediate intervention. Children presenting with poor growth and development. Children whose medical diets involve severe dietary restrictions.